Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 60505-2580

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60505-2580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

A line graph comparing the cumulative incidence (%) over time in years (0 to 3.5) between Atorvastatin and Placebo groups. The graph shows two lines: a solid line for Atorvastatin and a dashed line for Placebo, with Atorvastatin consistently lower. A hazard ratio (HR) of 0.64 and p-value of 0.0005 are noted at the bottom right of the graph.*

FDA Label Image

Figure-02 (Figure 02)

A line graph comparing cumulative hazard percentage over time (up to four years) for placebo versus atorvastatin treatment. The graph shows a higher cumulative hazard for placebo consistently compared to atorvastatin, with the x-axis labeled as time to first primary endpoint in years and y-axis as cumulative hazard percentage. Hazard ratio (HR) and significance value (p=0.001) are noted on the graph.*

FDA Label Image

Figure-03 (Figure 03)

A line graph comparing the percentage of subjects experiencing an event over time between Atorvastatin 10 mg and 80 mg doses. The x-axis represents time in years to the first major cardiovascular endpoint, up to 5 years. The y-axis shows the percentage of subjects experiencing an event. The graph includes a hazard ratio (HR) and p-value indicating statistical analysis results for the comparison.*

FDA Label Image

Btl-lbl-10mg-90s.jpg (Btl Lbl 10mg 90s)

Label for Atorvastatin Calcium Tablets, USP 10 mg by Apotex Corp. The label states the package contains 90 film-coated tablets and includes storage instructions, dosage form, strength, and manufacturer information. The NDC is 60505-2578-9.*

FDA Label Image

Btl-lbl-20mg-90s.jpg (Btl Lbl 20mg 90s)

Label for Atorvastatin Calcium Tablets, USP 20 mg, film-coated oral tablets by Apotex Corp. The label indicates a count of 90 tablets and includes storage instructions, dispensing guidance, and a barcode. It also shows the NDC number 60505-2579-9 and manufacturer details for Apotex in Ontario, Canada, and Weston, Florida.*

FDA Label Image

Btl-lbl-40mg-90s.jpg (Btl Lbl 40mg 90s)

Label for Atorvastatin Calcium Tablets USP 40 mg by Apotex Corp. The label indicates a 90-tablet count with storage instructions and dispensing guidance. It includes the NDC 60505-2580-9 and manufacturer information for Apotex Inc. The label highlights pharmacist dispensing with patient information available online.*

FDA Label Image

Btl-lbl-80mg-90s.jpg (Btl Lbl 80mg 90s)

Label for Atorvastatin Calcium Tablets, USP 80 mg film-coated tablets by Apotex Corp. The label indicates a package containing 90 tablets with NDC 60505-2671-9. It includes storage instructions, manufacturing details, and pharmacist dispensing information.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium, showing the molecular arrangement including calcium ions and organic groups characteristic of this active ingredient used in oral film-coated tablets by Apotex Corp.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.